TABLE 6 and 7: Microscopically verified

Percentage (%) of microscopically verified cases (persons)
Country average (population) Country average (country) England Scotland Wales1 Northern Ireland Republic of Ireland
All invasive xnmsc 84.8% 84.3% 85.1% 82.1% 83.4% 86.3%
All xnmsc 0-24 93.6% 92.7% 93.6% 96.6% 85.0% 95.7%
All xnmsc 25-59 96.2% 96.1% 96.3% 95.8% 95.3% 97.1%
All xnmsc 60-79 88.6% 87.7% 89.0% 85.8% 87.2% 88.6%
All xnmsc 80+ 62.8% 62.0% 63.5% 56.4% 62.4% 65.5%
All registrations 89.6% 89.4% 89.7% 88.1% 88.9% 90.9%
Haematology 87.4% 89.1% 86.9% 95.9% 80.8% 92.9%
Head and Neck 97.5% 97.8% 97.6% 96.3% 98.3% 99.1%
Lower GI 88.6% 88.5% 88.8% 86.7% 88.5% 90.1%
Upper GI 92.9% 92.4% 93.2% 91.7% 91.7% 93.0%
HPB 52.2% 51.2% 53.2% 41.7% 47.5% 62.5%
Trachea, Bronchus & Lung 68.9% 67.4% 69.7% 63.1% 68.9% 68.0%
Melanoma of skin 99.6% 99.7% 99.6% 99.8% 99.3% 100.0%
Breast 98.7% 98.7% 98.7% 98.7% 98.1% 99.4%
Cervix 97.8% 98.3% 97.8% 97.8% 97.6% 100.0%
Other Female Genitals 94.6% 94.1% 94.9% 92.7% 93.0% 96.0%
Prostate 85.7% 85.5% 85.8% 82.5% 87.4% 86.3%
Kidney 74.2% 73.4% 74.5% 72.8% 69.6% 76.7%
Bladder 90.1% 90.1% 90.3% 87.0% 90.3% 92.6%
Brain and CNS 70.3% 66.3% 71.1% 70.7% 59.5% 63.8%
Thyroid & other endocrine glands 97.1% 96.0% 97.3% 95.4% 94.1% 97.2%
CUP 45.3% 42.0% 46.2% 40.0% 44.7% 37.3%
Other invasive cancer 86.2% 84.1% 86.9% 80.8% 83.2% 85.7%
Breast in situ 99.9% 100.0% 99.9% 100.0% 100.0% 100.0%
Cervix in situ 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Other tumours 87.8% 87.8% 87.4% 92.5% 80.0% 91.0%
Percentage (%) of non-specificity of morphology codes for cases which are microscopically verified
Country average (population) Country average (country) England Scotland Wales1 Northern Ireland Republic of Ireland
All invasive xnmsc 1.2% 1.3% 1.2% 1.1% 1.5% 1.6%
All xnmsc 0-24 0.5% 0.7% 0.4% 0.7% 0.7% 0.9%
All xnmsc 25-59 0.8% 0.7% 0.8% 0.6% 0.6% 0.6%
All xnmsc 60-79 1.1% 1.2% 1.1% 1.0% 1.3% 1.5%
All xnmsc 80+ 2.4% 3.0% 2.4% 2.2% 3.2% 4.1%
All registrations 0.9% 1.3% 0.9% 0.9% 0.9% 2.6%
Haematology 0.8% 0.7% 0.8% 0.3% 0.7% 0.9%
Head and Neck 0.9% 1.1% 0.9% 0.8% 0.7% 2.1%
Lower GI 0.7% 0.6% 0.7% 0.2% 1.2% 0.3%
Upper GI 1.2% 1.2% 1.1% 1.9% 0.6% 1.3%
HPB 5.0% 6.1% 4.8% 4.1% 6.7% 8.5%
Trachea, Bronchus & Lung 2.1% 2.4% 2.1% 1.9% 2.7% 3.1%
Melanoma of skin 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Breast 0.9% 1.0% 0.9% 1.1% 0.7% 1.2%
Cervix 0.6% 0.3% 0.7% 0.4% 0.0% 0.0%
Other Female Genitals 0.9% 1.0% 0.9% 1.2% 1.4% 0.6%
Prostate 0.5% 0.3% 0.6% 0.0% 0.7% 0.1%
Kidney 1.1% 1.6% 1.1% 0.5% 1.4% 3.4%
Bladder 0.6% 0.6% 0.6% 0.4% 0.6% 0.9%
Brain and CNS 0.2% 0.1% 0.2% 0.0% 0.0% 0.0%
Thyroid & other endocrine glands 1.8% 2.0% 1.8% 1.7% 3.9% 0.7%
CUP 16.9% 19.6% 16.6% 16.6% 18.2% 27.0%
Other invasive cancer 0.8% 1.0% 0.8% 1.0% 0.8% 1.2%
Breast in situ 0.1% 0.1% 0.1% 0.4% 0.0% 0.0%
Cervix in situ 0.1% 0.1% 0.1% 0.0% 0.1% 0.3%
Other tumours 2.4% 4.0% 1.9% 1.8% 1.7% 10.5%

1 Data for Wales is on the preceding year.